标题: | Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells |
时间: | 2021-02-20 09:39:13 |
DOI: | 10.1038/s41556-019-0299-0 |
PMID: | 30936474 |
大小: | 4356 kb |
页数: | 21 PAGES |
下载: | 点击下载 |
预览: |
目录:
- Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of ...
- Results
- TAMs enhance aerobic glycolysis and inhibit apoptosis of breast cancer cells.
- TAMs enhance aerobic glycolysis and inhibit apoptosis of breast cancer cells by stabilizing HIF-1α protein.
- TAMs enhance aerobic glycolysis of breast cancer cells by EV-packaged lncRNA.
- HISLA transmitted by TAM EVs enhances aerobic glycolysis and induces apoptosis resistance in breast cancer cells.
- Lactate in the tumour microenvironment upregulates HISLA in TAMs.
- HISLA stabilizes HIF-1α by interfering in PHD2 and HIF-1α interactions.
- TAMs release HISLA in EVs to enhance glycolysis and chemoresistance of breast cancer in vivo.
- HISLA correlates with tumour glycolysis and chemoresistance of patients with breast cancer.
- Discussion
- Online content
- Acknowledgements
- Fig. 1 TAMs enhance aerobic glycolysis and inhibit apoptosis of breast cancer cells.
- Fig. 2 TAMs enhance aerobic glycolysis and inhibit apoptosis of breast cancer cells by stabilizing HIF-1α protein.
- Fig. 3 TAMs enhance the aerobic glycolysis of breast cancer cells by EV-packaged lncRNA.
- Fig. 4 HISLA transmitted by TAM EVs enhances aerobic glycolysis and induces apoptosis resistance in breast cancer cells.
- Fig. 5 Lactate in the tumour microenvironment upregulates HISLA in TAMs.
- Fig. 6 HISLA stabilizes HIF-1α by blocking PHD2 and HIF-1α interactions.
- Fig. 7 TAMs release HISLA in EVs to enhance glycolysis and induce chemoresistance in breast cancer in vivo.
- Fig. 8 HISLA correlates with tumour glycolysis and chemoresistance of patients with breast cancer.
- Results
本页内容由网络收集而来,版权归原创者所有,如有侵权请及时联系